10 Worst ADR Stocks To Buy According to Short Sellers
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank that represents shares of a foreign company. These certificates allow U.S.
Urogen Pharma Ltd. (URGN)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2024 Second Quarter UroGen Pharma Earnings Call. [Operator Instructions] Please advise that today’s conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Thank you for standing by. Welcome to the UroGen Pharma First Quarter 2024 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Full Year 2023 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and thank you for standing by, and welcome to the UroGen Pharma Q3 2023 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. And welcome to the UroGen Pharma’s Second Quarter 2023 Earnings Call.
UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today's conference is being recorded.
UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. And welcome to the UroGen Pharma Q4 2022 Earnings Call. At this time, all participants are in a listen-only mode.
10 Best Immunotherapy Stocks To Buy Now
The global immunotherapy market is rapidly evolving as technological, regulatory, and economic trends combine to alter the growth and risk dynamics within the industry.
10 Micro-Cap Stocks To Buy According To Cathie Wood
In this article, we discuss the 10 micro-cap stocks to buy according to Cathie Wood.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
